Identifying genetic risks for autism in newborns
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
This study is looking at the genes of newborns to find clues about autism, hoping to help families get early diagnoses and support before any signs show up, while also learning how early help can make a difference for kids at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10916374 on NIH RePORTER |
What this research studies
This research focuses on identifying genetic variants associated with autism in newborns, aiming to provide early diagnoses before symptoms appear. By utilizing genomic sequencing, the study will analyze a diverse cohort of infants to understand their neurobehavioral development and the impact of genetic information on families. The research will also explore how early intervention can improve outcomes for children at risk of autism. Parents will be involved in the process, providing insights into their experiences with receiving genetic information.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns identified as genetically at risk for autism, particularly those from diverse backgrounds.
Not a fit: Patients who are not newborns or do not have a genetic predisposition to autism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and intervention for children at risk of autism, potentially improving their developmental outcomes.
How similar studies have performed: Previous research has shown promise in using genetic screening for early diagnosis of autism, making this approach a continuation of successful methodologies.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Veenstra-Vanderweele, Jeremy — Columbia University Health Sciences
- Study coordinator: Veenstra-Vanderweele, Jeremy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.